What happens when a trial ends?
And what about other trials? What happens if you enjoy tremendous success with a drug that is being tested and the trial ends? Must you then give up on that drug and find another, and hope you live long enough to see the drug you really want wind it's way to FDA approval? Yikes.
Now some old hands at this might smile at my naïveté, knowing that all drugs have limited effectiveness. But, wading into the waters here, us newbies cling to the gold standard, those wonderful success stories of folks benefitting from the same drug for years and years.
(sigh) This is such a chess game, isn't it?
Comments
-
I know with MDX-1106pjune127 said:I don't know either
Don't ever feel stupid. I don't know the answer to that question either and I need to know for sure! Certainly someone knowledgeable on these boards knows the answer. If not I will ask when I go back to Nashville on 11/8.
the trial lasts 2 years for those who continue to have positive results. If, after the 2 years you stop and show progression, they will allow you one more year on it. After that, you are cut off, period. I guess the hope is that it is FDA approved by then.
Don't know the answer to your case.0 -
All my trials, Lordpjune127 said:I don't know either
Don't ever feel stupid. I don't know the answer to that question either and I need to know for sure! Certainly someone knowledgeable on these boards knows the answer. If not I will ask when I go back to Nashville on 11/8.
Different in the UK, I don't doubt, and I'm not the knowledgeable person you need. (I feel certain an accurate answer could be had at once on ACOR.)
Meantime, it's interesting to know that there are folks around who've been on Avastin for 8 years. It was FDA-approved for use with interferon alpha in 2009 (approval rescinded for use in breast cancer treatment in Nov 2011 and there have been scares lately about counterfeit Avastin - the only legit source being from Genentech, part of the Roche Gp).
Presumably there are separate issues of its post trial accessibility prior to FDA approval (and cost issues, also, of course) and its continued viability as treatment, which must vary enormously between individuals?
When you're in Nashville, Paula, I hope you'll 'record' your results!0 -
4 yearsTexas_wedge said:All my trials, Lord
Different in the UK, I don't doubt, and I'm not the knowledgeable person you need. (I feel certain an accurate answer could be had at once on ACOR.)
Meantime, it's interesting to know that there are folks around who've been on Avastin for 8 years. It was FDA-approved for use with interferon alpha in 2009 (approval rescinded for use in breast cancer treatment in Nov 2011 and there have been scares lately about counterfeit Avastin - the only legit source being from Genentech, part of the Roche Gp).
Presumably there are separate issues of its post trial accessibility prior to FDA approval (and cost issues, also, of course) and its continued viability as treatment, which must vary enormously between individuals?
When you're in Nashville, Paula, I hope you'll 'record' your results!
I've been told that my trial could last up to 4 years. I guess that is as long as I demonstrate a positive response. I hope I have nothing to respond long before that.0 -
Chess
As I understand it in Australia, unless a drug is FDA approved at the end of a trial, the patient can either participates in another study, or revert to receiving the standard level of treatment for their illness. This is regardless of whether or not the drug worked for them. A chess game indeed. Couldn't have said it better myself.0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.9K Cancer specific
- 2.8K Anal Cancer
- 446 Bladder Cancer
- 309 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 398 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.4K Kidney Cancer
- 671 Leukemia
- 794 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 237 Multiple Myeloma
- 7.1K Ovarian Cancer
- 63 Pancreatic Cancer
- 487 Peritoneal Cancer
- 5.5K Prostate Cancer
- 1.2K Rare and Other Cancers
- 540 Sarcoma
- 734 Skin Cancer
- 654 Stomach Cancer
- 191 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.9K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards